文献速递胃肠外科围术期管理与 ERAS

腹腔镜减重术后院内阿片类药物使用预测出院阿片类处方需求

Hospital opioid use predicts the need for discharge opioid prescriptions following laparoscopic bariatric surgery.
PubMed 文献 · Surg Endosc · 2022-01-13

该回顾性队列研究分析84例腹腔镜袖状胃切除术(LSG,72例)和腹腔镜Roux-en-Y胃旁路术(LGB,12例)患者,65%出院时获阿片类处方,91%取药,但仅44%取药者实际服用,总处方药片仅24%被消耗。院内阿片使用与出院阿片使用强相关(rho=0.65,CI 0.494,0.770),术后90天内无患者需额外阿片处方。

要点

  • 出院阿片处方中仅24%药片被实际消耗,存在过度处方。
  • 院内阿片使用与出院使用强相关(rho=0.65,CI 0.494,0.770)。
  • 术后90天内无患者需额外阿片处方(MAPS确认)。

核心结论

  • 腹腔镜减重术后院内阿片使用可预测出院后阿片使用,可指导患者个体化出院阿片处方。

研究设计与样本

  • 回顾性队列研究,单机构,分析2019年7月至2020年2月行LSG(72例)和LGB(12例)患者共84例。

主要发现

  • 院内阿片使用与出院阿片使用相关系数rho=0.65(CI 0.494,0.770)。
  • 院内服用0片、1-3片、4片及以上者出院后消耗药片分别为0.14±0.48、0.95±1.71、3.14±1.86片(p<0.001)。
  • 术后90天内无患者需额外阿片处方(MAPS确认)。

关键数值与推荐

  • 多模式镇痛包括住院期间按需5 mg羟考酮片,讨论后如要求出院带5片。

临床怎么用

  • 可根据院内阿片使用情况指导腹腔镜减重术后患者个体化出院阿片处方。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Overprescribing of opioids after surgery increases new persistent opioid use and diversion contributing to the opioid epidemic. There is a paucity of evidence regarding discharge opioid prescribing after bariatric surgery. METHODS: We conducted a retrospective, cohort study analyzing post-operative opioid use at a single institution in patients who underwent laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LGB) from July 2019 thru February 2020. Multimodal analgesia was used including 5 mg oxycodone pills as needed during hospitalization with five prescribed on discharge if requested after discussion. Opioid use was determined from medical record review and post-operative data collected from patients at a 2-week follow-up visit. The Michigan Automated Prescription System (MAPS) was used as an adjunct to evaluate perioperative opioid prescriptions. RESULTS: The cohort of 84 patients included those having LSG (72) and LGB (12). Fifty-five patients (65%) received a prescription for opioids on discharge and 91% filled their prescription. Only 44% (22/50) of those filling their opioid prescription took any opioids with 24% (65/275) of the total pills prescribed actually consumed. Opioid use on the surgical ward had the strongest correlation with discharge opioid use (rho = 0.65, CI 0.494, 0.770). The number of opioid pills taken on the surgical ward was positively associated with the number of pills taken after discharge. Those who took none, 1 to 3, or 4 or more opioid pills consumed 0.14 ± 0.48, 0.95 ± 1.71, and 3.14 ± 1.86 pills after discharge (p < 0.001). No patients required an additional opioid prescription within 90 days of surgery with MAPS confirmation. CONCLUSION: Postoperative in-hospital opioid use following laparoscopic bariatric surgery predicts opioid use after discharge. This knowledge can guide patient-specific discharge opioid prescribing with the potential to mitigate diversion and reduce chronic opioid use.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Diaz SE, Dandalides AM, Carlin AM, et al. Hospital opioid use predicts the need for discharge opioid prescriptions following laparoscopic bariatric surgery. Surg Endosc. 2022. PMID: 35024936. doi:10.1007/s00464-022-09035-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。